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Abstract
Aims: The dynamics and topographical distribution of SOX17 and SOX2 expres-
sion was studied in the transformation zone (TZ) of the uterine cervix. This TZ is a 
dynamic area where switches from glandular into squamous epithelium can be rec-
ognized, new squamocolumnar junctions are formed, and premalignant lesions origi-
nate. SOX17 and SOX2 show mutually exclusive expression patterns in the normal 
uterine cervix, with SOX2 being exclusively found in squamous epithelium, while 
SOX17 is detected in endocervical columnar cells and reserve cells.
Methods and Results: Normal cervices and squamous intraepithelial lesions (SIL) 
were studied with immunohistochemistry, methylation of SOX17, human papilloma 
virus (HPV) genotyping, and in situ hybridization. In the TZ squamous metaplasia 
originating from these reserve cells can still show SOX17 expression, while also 
remnants of SOX17-positive immature metaplasia can be recognized in the normal 
squamous epithelium. SOX17 expression is gradually lost during maturation, result-
ing in the exclusive expression of SOX2 in the majority of (SIL). This loss of SOX17 
expression is independent of methylation of the CpG island in its promotor region. 
HPV can be detected in SOX17-positive immature metaplastic regions in the im-
mediate vicinity of SOX2-positive SIL, suggesting that switches in SOX17 and 2 
expression can occur upon HPV infection.
Conclusions: This switch in expression, and the strong association between the 
distribution of reserve cells and squamous areas within the columnar epithelium in 
the TZ, suggests that reserve cell proliferations, next to basal cells in the squamous 
epithelium, are potential targets for the formation of squamous lesions upon viral 
infection.
K E Y W O R D S
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1 |  INTRODUCTION
The premalignant lesions of the uterine cervix originate 
in the transformation zone (TZ), an area where endocervi-
cal columnar cells are replaced by squamous epithelium. 
These two epithelial tissue types merge at the squamoco-
lumnar junction (SqCJ). 1-6 The process of epithelial re-
placement, taking place proximal to this mucosal junction, 
is called squamous metaplasia. It can be observed before 
birth and is particularly prominent during adolescence.6-9 
Squamous metaplasia is the result of proliferation and 
maturation of a unique subset of progenitor cells, the so-
called reserve cells, which are sporadically seen under en-
docervical columnar cells up to the second junction at the 
beginning of the endometrium.1,7,10 Upon differentiation, 
reserve cells acquire squamous characteristics, initially 
forming immature squamous metaplastic epithelium, sub-
sequently maturating into a squamous epithelium that is 
indistinguishable from the original ectocervical squamous 
epithelium.6
There is a general consensus that reserve cells can be re-
garded as a progenitor cell population, capable of generating 
squamous type epithelium.6,11-13 Several models have been 
proposed to describe the origin of reserve cells and their 
involvement in the formation of premalignant lesions.6,14-16 
Both squamous and glandular-type carcinomas develop in the 
cervical TZ, which is an important argument for the hypothe-
sis that the reserve cell plays a central role in the pathogenesis 
of these malignancies.11-13,17-19 It is widely speculated that as 
a result of persistent human papilloma virus (HPV) infection 
in the TZ, the normal proliferation and differentiation of re-
serve cells may be derailed and a precursor lesion for these 
cervical carcinomas develops.20,21 It has been demonstrated 
that atypical reserve cell proliferations harbor oncogenic 
HPV types, thereby confirming early studies, which were 
based on morphologic observations, sometimes in combi-
nation with biomarkers.17,22,23 These also provided evidence 
that the reserve cell is the progenitor for cervical carcinomas 
and their precursor conditions.
On the basis of marker expression patterns, particularly 
of keratin 7, this theory has been challenged by Herfs et al15 
These authors identified a small population of keratin 7-pos-
itive cuboidal cells in the vicinity of the SqCJ, which were 
speculated to be the progenitors of high-grade squamous 
intraepithelial lesions (HSIL). Furthermore, these cuboidal 
cells were suggested to undergo reverse differentiation into 
(basal) reserve cells, which in turn can undergo metaplastic 
changes. However, in earlier studies,7,16,24 in which keratin 
phenotypes of the uterine cervix were analyzed both during 
embryonal development and malignant transformation, we 
found extensive expression of keratin 7 in all endocervical 
epithelial cells. On the basis of these results, and additional 
studies with stem cell markers,8,17 it was concluded that 
reserve cells are potential progenitors of both squamous- and 
glandular cervical lesions.
In the underlying study, we examined the role of the cell 
lineage markers SOX17 and SOX2, transcription regulator 
proteins playing a pivotal role in human development.25,26 
These markers have been studied so far only separately 
during the development of cervical cancer. It was suggested 
previously that SOX2 expression increased with severity of 
SIL lesions, but the data in literature are contradictory.27-33 
The expression of SOX17, on the other hand, decreases with 
severity of the lesion and the majority of squamous and glan-
dular (pre)malignant lesions of the uterine cervix have been 
described to show methylation of the promoter CpG island 
region of the SOX17 gene.34,35
Recently, we showed that SOX17 and SOX2 exhibit a 
mutually exclusive expression pattern in the normal cervical 
epithelium, with SOX17 exclusively being found in the glan-
dular epithelium and SOX2 exclusively expressed in the squa-
mous epithelium. A sharp delineation of these two expression 
patterns was seen at the old and new SqCJs (NSqCJs).35 
Interestingly, the reserve cells underlying the glandular epi-
thelium were found to be SOX17 positive. When studying the 
topographical distribution of these two markers in squamous 
and glandular preneoplastic lesions (SIL and adenocarci-
noma in situ; AIS), we noted an almost exclusive expression 
of SOX2 in SIL and a more complex, combined SOX2 and 
SOX17 expression pattern in AIS. Furthermore, we could 
show an unexpected downregulation of SOX17 in a fraction 
of AIS lesions, which could be explained by the methylation 
status of its gene promotor region.
Triggered by these earlier, more static findings we now 
wanted to study the dynamics of SOX2 and SOX17 expres-
sion in the carcinogenesis of the uterine cervix, with a focus 
on the origin of the very early stages of squamous preneo-
plasia and the role of the reserve cells in this process. As 
described above, in this respect, the TZ is an important area 
where switches from glandular into squamous epithelium can 
be recognized, NSqCJs are formed within the columnar ep-
ithelium6 and premalignant lesions originate.35 It is in such 
regions that we examined the relationship between the ex-
pression of the SOX17 and SOX2 transcription regulatory 
proteins in normal, hyperplastic, metaplastic, and premalig-
nant epithelium. In addition, the methylation status of SOX17 
was examined to explain the observed loss of expression of 
the protein during the development of metaplasia. The pres-
ence of reserve cell differentiation markers (ie, keratins 17 
and 7), markers for immature metaplasia (keratin 17 positiv-
ity and p16 negativity), as well as HPV type and physical 
status of the virus are also assessed.
Based on our findings, we provide new insights into the 
involvement of reserve cells and the metaplastic epithelium 
in the formation of preneoplastic squamous lesions in the TZ 
of the uterine cervix.
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2 |  MATERIALS AND METHODS
2.1 | Tissues
The following types of tissue samples were selected from the 
archives of the Departments of Pathology of the Foundation 
of Collaborating Hospitals in Eastern Groningen, Pathan 
Rotterdam, the Reinier de Graaf Hospital Delft, and the 
Maastricht University Medical Center, Maastricht, The 
Netherlands:
1. Formalin-fixed and paraffin-embedded (FFPE) tissues 
from 12 normal cervices removed for non-cervix-related 
conditions during hysterectomy of premenopausal women. 
In 11 of the 12 samples, reserve cells could be detected. 
There was no previous history of cervical abnormalities. 
To this end, patient history with regards to previous 
cervix smears, use of hormonal therapy, and any other 
relevant pathology was reviewed.
2. Formalin-fixed and paraffin-embedded tissues from rep-
resentative samples of cervical squamous (pre)neoplastic 
lesions were selected, including 17 cases of low-grade 
squamous intraepithelial lesions (LSIL), 33 cases of 
HSIL, and 20 cases of squamous cell carcinoma (SCC), 
as well as 10 SIL cases with co-existing AIS, of which 
two were LSIL and eight were HSIL. Within these tissue 
F I G U R E  1  SOX expression patterns 
in normal cervical epithelia. A-D, Mutually 
exclusive SOX2 (A, B) and SOX17 (C, 
D) immunostaining patterns of normal 
ectocervical squamous epithelium (A, C) 
and endocervical glandular epithelium (B, 
D). This switch in SOX expression is clearly 
seen at the SqCJ (E, F). SOX2 is negative in 
immature metaplastic epithelium (G), while 
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samples, we analysed 27 morphologically normal areas of 
squamous epithelium, including remnants of (immature) 
metaplasia distant from the lesions, as well 13 normal 
areas adjacent or in close proximity to the lesion. Sections 
were re-evaluated by two pathologists who selected rep-
resentative tissue blocks in each case. Regions with mi-
croglandular hyperplasia were occasionally found in these 
samples. In all these cases, SOX17 and SOX2 expression 
was assessed by immunohistochemistry.
From this series of eight LSILs and 10 HSILs, as well 
as five cases of co-existing SIL/AIS lesions were tested for 
methylation of SOX17. This series was also analysed for HPV 
by in situ hybridization (ISH) and immunostained for p16 
and the differentiation markers keratin 7 and 17 in individual 
cases (see below).
Research on these tissue samples has been performed 
in accordance with the Code for Proper Secondary Use of 
Human Tissue in The Netherlands (http://www.federa.
org/, update 2011) and has been approved by the Medical 
Ethical Committees of the Erasmus University Medical 
Centre, Rotterdam (registration numbers MEC 02-981 and 
CCR2041) and of the Foundation of Collaborating Hospitals 
of Eastern Groningen, the Netherlands.
2.2 | Immunohistochemistry
Immunohistochemical staining on 4-µm thick FFPE tissue 
sections was performed using primary antibodies against 
SOX17, SOX2, keratin 7, keratin 17, and p16. Detailed infor-
mation on antibodies and immunostaining conditions is sum-
marized in the Materials and Methods S1, and in Table S1. 
The sections were scanned with a Ventana iScan HT slide 
scanner (Ventana Medical Systems, Inc) and semi-quanti-
tatively scored for expression of SOX17, SOX2, keratin 7, 
keratin 17, and p16. Images were viewed and selected using 
Image Viewer Software (Ventana MS).
2.3 | HPV genotyping and detection by ISH
HPV genotyping was performed with the multiplex ligation-
dependent probe amplification assay (MLPA) or the Single 
tube Multiplex Amplification in Real Time (SMART) kit 
(PathoFinder).36,37 HPV typing was performed on DNA iso-
lated from 4-µm thick FFPE tissue sections or DNA iso-
lated from cytological samples matching with the tissue 
obtained after colposcopy and processed for histological 
examination.
F I G U R E  2  SOX expression patterns 
in metaplastic cervical epithelia. A and B, 
SOX2 (A) and SOX17 (B) immunostaining 
in corresponding areas morphologically 
classified as mature squamous epithelium, 
showing alternating and mutually exclusive 
expression of SOX2 and SOX17. C-F, 
SOX2 is negative in immature metaplastic 
epithelium (C), while this epithelium is 
positive for SOX17 (D), with the strongest 
expression in the basal cell layers. Immature 
metaplastic squamous epithelium is 
characterized by a strong positivity for 
keratin 17 mainly in the basal cell layers 
(E) and a slightly weaker, more superficial 
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HPV was detected in FFPE tissue sections by means of 
ISH, using either fluorescence (FISH) or chromogenic detec-
tion (CISH), with DNA probes for HPV 16, 18, and 31. For a 
detailed description of HPV ISH, see Materials and Methods 
S1. The FISH and CISH signals were classified according to 
their distribution patterns, typical for the presence of episomal 
viral copies, viral replication or viral integration into the human 
genome.38
F I G U R E  3  SOX expression patterns in cervical reserve cells. SOX17 immunostaining of reserve cells in normal epithelium found in cases 
of microglandular hyperplasia (A-J) and SIL (K-P). A-E, SOX17 immunoreactivity in endocervical glandular epithelium and reserve cells (A), 
microglandular hyperplasia (C), and in early immature metaplasia (D, E). F-J, Increasing expression of SOX2 is seen upon development of 
immature metaplasia (F, H-J). Keratin 17 (B) shows a specific immunostaining reaction in the reserve cell compartment, while keratin 7 (G) 
additionally also stains the columnar/glandular epithelial cells. K-P, SOX 17 positivity (K) in keratin 17 (L) and keratin 7 (M)-positive reserve cells 
in a case of high-grade squamous intraepithelial lesions. These stretches of reserve cells may be positioned in close proximity to the HPV-positive 
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2.4 | SOX17 promotor CpG island 
methylation
DNA was isolated from cells manually dissected from FFPE 
sections. The areas of dissection were selected on basis of 
p16 and SOX17 immunostaining, or ISH HPV positivity (see 
Materials and Methods S1). DNA was bisulfite treated (using 
the EZ DNA Methylation-Direct Kit; Zymo Research) and 
after conversion, the potentially methylated SOX17 DNA was 
amplified. Subsequently, specific primers for the methylated 
and unmethylated CpG island were applied (Table S2).39,40
3 |  RESULTS
3.1 | Expression patterns of SOX17 and 
SOX2 in normal and metaplastic adult cervical 
epithelia
Normal adult cervical epithelia, defined as such by their mor-
phology and the fact that they are HPV negative, were analysed 
in the 12 normal cervices and in 23 cases of cervical preneo-
plasia. As shown before,35 these normal epithelia of the uterine 
cervix show a mutually exclusive expression pattern for SOX17 
and SOX2, with an abrupt transition at the SqCJ between the 
endocervical epithelium and the squamous type epithelium. 
The squamous epithelium is characterized by a nuclear staining 
of SOX2 throughout the epithelial thickness, with exception of 
the most superficial cells and the strongest immunostaining in 
the basal cell compartment (Figure 1A,E). In contrast, SOX17 
is not found in the ectocervical squamous epithelium (Figure 
1C,F), but is extensively expressed in the endocervical colum-
nar epithelium (Figure 1D,F) which is SOX2 negative (Figure 
1B,E). New SqCJs are formed within the columnar epithelium 
in the TZ, typically showing small fields of squamous meta-
plasia bordering the cervical epithelial invaginations (shown 
in an overview in Figure S1A,B). In contrast to what is seen 
in the squamous epithelium of the original SqCJ (OSqCJ), 
these regions of immature squamous metaplasia can show a 
strong immunostaining for SOX17 (Figure 1H), but are gener-
ally negative for SOX2 (Figure 1G) or can occasionally show 
a weak cytoplasmic reactivity for this marker (Figure S1C,D).
In such an adult TZ, which is a dynamic area of a few mil-
limeters in length, stretches of SOX2-positive and SOX17-
negative squamous epithelium can alternate with areas of 
SOX17-positive and SOX2-negative regions (compare Figure 
2A,B). Such SOX17-positive areas were seen in 2 out of 12 
(16.7%) normal cases and in 5 out 23 (21.7%) samples of the 
morphologically normal squamous epithelia adjacent to SIL 
lesions (see also Figure 2C,D). They were characterized by a 
strong positive immunostaining for keratin 17 (Figure 2E), a 
weaker keratin 7 staining (Figure 2F), and absence of HPV, 
either concluded on basis of absence of p16 or a negative 
HPV ISH (results not shown). Based on these characteristics, 
and their squamoid morphology, these SOX17-positive areas 










LSIL n = 17 1 12 3 1
HSIL n = 33 0 26 4 3
Co-existent SIL/AIS n = 10 SIL 1 7 1 1
AIS 5 1 3 1
SCC n = 20 0 20 0 0
Abbreviations: AIS, adenocarcinoma in situ; HSIL, high-grade SIL; LSIL, low-grade squamous intraepithelial 
lesion; SCC, squamous cell carcinoma.
T A B L E  1  Overview of SOX17 and 
SOX2 expression patterns in (pre)malignant 
lesions of the uterine cervix. The different 
classes of SOX17 and SOX2 combinations 
are based on staining intensity and 
percentage of positive cells
F I G U R E  4  Switches in the expression of SOX2 and SOX17 in the transition of normal epithelium to high-grade squamous intraepithelial 
lesions (HSIL). Low magnification of a section stained for p16 showing negative normal epithelia and a positive HSIL lesion (A). The boxes 1-3 
in this figure indicate epithelial transitions within the normal epithelium (box 1: a transition between normal and metaplastic squamous epithelium, 
possibly the original squamocolumnar junction), a new squamocolumnar junction (box 2), and the transition between HSIL and glandular 
epithelium (box 3). The fact that glands are seen beneath the squamous epithelium between boxes 1 and 2 (arrowhead) indicates that this region 
can be regarded as the transformation zone. The higher magnifications of these areas (B-M) illustrate the mutually exclusive expression of SOX2 
and SOX17 in these transitions. This is again evident in the keratin 17- and keratin 7-negative normal ectocervical squamous epithelium in the 
p16-negative area (left epithelial area in B, E, H, K). The keratin 17- and keratin 7-positive metaplastic epithelium (right epithelial area in B, E, H, 
K) shows an extensive SOX17 positivity in the basal and intermediate compartment, and in this case SOX2 positivity in the superficial layers. In 
the strongly keratin 17-positive squamous epithelium close to the new SqCJ only SOX17 is expressed, while SOX2 expression is absent (C, F, I, 
L). This SOX expression pattern is reversed in HSIL as identified by expression of keratins 7 and 17, where SOX2 expression is high and SOX17 
expression is absent (D, G, J, M; p16 positive area)
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3.2 | Expression of SOX17 in reserve cells
Although present in a scattered pattern in most of the cervi-
cal biopsies, reserve cells were easily found in the cases with 
microglandular hyperplasia. In these lesions, a strong SOX17 
positivity was noted in both reserve cells and columnar epi-
thelial cells (Figure 3A,C), which were negative for SOX2 
(Figure 3F,H). Reserve cells can be identified by a strong im-
munostaining reaction for keratin 17 and to a lesser extent by 
keratin 7 positivity (Figure 3B,G). Upon metaplastic trans-
formation, SOX17 and SOX2 show co-expression in small 
focal, basal areas (compare Figure 3D,I), which upon further 
development change into a SOX2-positive hyperplastic epi-
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(Figure 3E,J). Reserve cells found in cases of SIL, as identi-
fied by their keratin 17 (Figure 3L) and keratin 7 (Figure 3M) 
expression pattern, are also SOX17 positive (Figure 3K) and 
SOX2 negative (result not shown). These stretches of reserve 
cells can be found adjacent to or in close proximity to the 
premalignant lesion (Figure 3N-P).
3.3 | Expression of SOX17 and SOX2 in 
squamous (pre)malignant lesions
The expression patterns of SOX17 and SOX2 were semi-
quantitatively assessed in 80 cases of squamous premalig-
nant (SIL; n  =  60), including 10 cases of co-existing SIL/
AIS lesions, and malignant lesions (SCC; n = 20) (Table 1). 
In 53 out of the 60 (88.3%) SIL lesions (both LSIL and HSIL 
and including the SIL lesions in the co-existing SIL/AIS), an 
exclusively SOX2-positive staining pattern (n  =  45; 75%) 
or dominant expression (n = 8; 13.3%) of SOX2 was seen. 
In these positive lesions, at least 20% of the cells expressed 
SOX2 with the strongest staining intensity in the basal cell 
compartment. Only two cases showed a dominant or exclu-
sive expression of SOX17, while five cases were completely 
negative for both SOX2 and SOX17. Co-expression of 
SOX17 with SOX2 was found in 8 out of 60 cases (13.3%). 
All 20 SCCs showed an exclusive SOX2 expression in 30%-
100% of the cells. In the co-existing squamous and glandular 
(SIL/AIS) premalignant lesions, the squamous component 
exclusively expressed SOX2 in 7 of the 10 (70%) cases, 
while most of the AIS regions were positive for SOX17, as 
described before.35
3.4 | Switches in SOX expression in the 
TZ of SIL lesions
Figure 4 illustrates the typical example of the epithelial 
trajectory from ectocervix to endocervix including sev-
eral SqCJs and a HSIL, with the glands underneath the 
squamous epithelium clearly visible (low magnification 
overview in Figure 4A). In the p16-negative normal squa-
mous epithelium (box 1 in Figure 4A), an abrupt change in 
SOX17/SOX2 expression is seen. In the ectocervical part 
of the epithelium, the typical SOX2-positive and SOX17-
negative profile is recognized (Figure4B,E). Cranial from 
this junction the squamous epithelium becomes basally 
SOX17 positive and SOX2 negative, but remains superfi-
cially partly positive for SOX2 (see Figure 4B,C,F showing 
a NSqCJ present in box 2). Keratin 17 showed staining of 
the basal epithelial layers (Figure 4H) or staining through-
out the total thickness of the epithelium (Figure 4I), while 
keratin 7 was only faintly and sporadically positive (Figure 
4K,L). The p16-positive HSIL lesion (shown in box 3 at a 
SqCJ) was SOX17 negative (Figure 4G), completely SOX2 
positive (Figure 4D) and expressed keratin 17 and keratin 7 
(Figure 4J,M).
3.5 | Correlation of switches in SOX 
expression to HPV infection in SIL
To answer the question whether or not HPV infection results 
in a switch of SOX expression, we studied the association 
between the topographic localization of SOX17 and SOX2 
expressing epithelia and the viral infection as detected by 
p16 and ISH, using 23 cases of SIL that could be studied in 
detail (Table 2). We focused on dysplastic and adjacent or 
co-existing metaplastic lesions close to the SqCJ, supposed 
to be the area at risk for viral infection.
Figure 5A-J show two cases in which the SIL lesion is 
infected by HPV (as detected by ISH and p16 immunos-
taining; Figure 5E,F,J) and where the infected regions abut 
to non-infected (remnants of) immature metaplasia. At this 
transition (indicated by the bars in Figure 5B-J), a switch in 
SOX expression is seen from a SOX2-negative and SOX17-
positive staining pattern in metaplasia to a SOX2-positive 
and SOX17-negative pattern in the infected SIL areas (Figure 
5B,C,G,H). This correlation between HPV infection and the 
switch in SOX expression was found in 3 out of 13 cases 
(23.1%) of SIL where squamous metaplasia (characterized by 
a strong positive immunostaining for keratin 17 and keratin 
7; Figure 5D,I) was found adjacent or in close proximity to 
SIL (see Table 3).
In co-existing SIL/AIS lesions, SOX17 expression was 
exclusively found in the glandular compartment, while SOX2 
can be found in both the glandular and squamous compart-
ments (Table 2) as shown before.35
To further corroborate the findings as described above 
for the three areas in cases of co-existing metaplastic/dys-
plastic lesions, we studied the SOX expression patterns in 
27 areas of morphologically normal squamous epithelium, 
including remnants of (immature) metaplasia, distant from 
the SIL lesions. Table  3 shows that of these 27 regions 
of apparently normal/metaplastic squamous epithelium 
9 (33.3%) were exclusively positive for SOX17, while 17 
(63%) of these areas showed an exclusive SOX2 expression 
pattern.
3.6 | SOX17 Promotor CpG island 
methylation in squamous premalignant lesions
To explain the loss of SOX17 expression during the transi-
tion of reserve cells into SIL, the promotor CpG island meth-
ylation status of SOX17 was determined in these lesions. In 
normal squamous epithelium, which was used as control, the 
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examined CpG island in the promotor region of SOX17 was 
methylated in only 1 out of 19 cases (5.3%) (Table 2). Since 
downregulation of SOX17 protein expression is also seen in 
the transition of immature metaplasia into SIL, the methyla-
tion status of SOX17 was assessed in these squamous pre-
neoplastic lesions, of which 12 out of 18 cases (66.7%) did 
not show methylation, while in 6 of the 18 (33.3%) LSIL/
HSIL the promotor region was methylated, one case of 
LSIL and five cases of HSIL. In the co-existing SIL/AIS le-
sions, the association between methylation status and protein 
expression of SOX17 was lacking in SIL, while in AIS the 
loss of SOX17 expression runs parallel with the methylation 
of SOX17 as described before.35
4 |  DISCUSSION
The transition zone between glandular and squamous epi-
thelium in several types of mucosa has been described 
as a high-risk region for the development of metaplasia 
T A B L E  2  Overview of SOX17 and SOX2 expression as scored on basis of Ventana scans, in relation to SOX17 methylation status, HPV type, 

























18 n.a.  16
SIL/AIS
19 n.a./ / n.a./ 18 / / /
20 / / n.a. / 16 / / /
21 / / n.a./ 16 / /
22 / / / 16 / /
23 / / / 16 /
: No immunostaining, no methylation, not present.
: Positive nuclear immunostaining, methylation, present.
: Faint immunostaining, small fraction of methylated cells.
 : Two concurrent areas analyzed.
/ : SIL and AIS separately analyzed.
Abbreviations: AIS, adenocarcinoma in situ; HSIL, high-grade intraepithelial lesion; IHC, immunohistochemical staining; int, integrated HPV; LSIL, low-grade 
squamous intraepithelial lesions; n.a.: not available/not suitable for analysis; repl, replicating HPV; SqE, squamous epithelium.
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and (pre)neoplastic lesions.5,16,26,41 The debate about the 
cells of origin for these lesions is, however, still ongo-
ing.15,16,42,43 Neoplasia in the cervix is suggested to occur 
at particular epithelial sites, where vulnerable cells, such 
as the reserve cells or cuboidal cells, are found.14,15 The 
underlying study focuses on SOX2 and SOX17 expression 
during (pre)neoplastic transformation of the uterine cer-
vix. In an earlier study, we found a mutually exclusive ex-
pression pattern of these transcription factors at the SqCJs 
in the normal TZ of the adult cervix.35 In the underlying 
study, we use their expression patterns to explain the pro-
cesses taking place in the dynamic area of the TZ during 
F I G U R E  5  Switches in expression of SOX2 and SOX17 in relation to high risk human papilloma virus infection in SIL. Low magnifications 
of high-grade squamous intraepithelial lesions (HSIL) lesions immunostained for SOX17 (A) and p16 (F). These cases show switches in SOX 
expression in areas containing the keratin 7-positive HSIL (I) lesions next to keratin 17-positive (immature) metaplasia (D). The metaplastic areas 
show SOX17 positivity (B, G) and no expression of SOX2 (C, H). Only the SOX2-positive regions show HPV 16 positivity as detected by in situ 







T A B L E  3  SOX expression patterns in areas of morphologically normal squamous epithelium (40 areas in 18 SIL cases) either distant from (27 










Morphologically normal areas of squamous 
epithelium including remnants of (immature) 
metaplasia
n = 27 9 17 0 1
Morphologically normal squamous epithelium 
adjacent to squamous intraepithelial lesion (SIL) 
including (remnants) of immature metaplasia
LSIL
n = 8 1 7 0 0
HSIL
n = 5a 2 3 0 0
SIL LSIL
n = 8 0 7 0 1
0 10 0 0
HSIL
n = 10
Abbreviations: HSIL, high-grade intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesions.
aFrom the 10 samples of HSIL shown in Table 2, only 5 showed morphologically normal squamous epithelium adjacent to the HSIL. 
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the formation of metaplasia and upon HPV infection re-
sulting in SIL.3,9 This TZ is situated between the OSqCJ 
and the NSqCJ, in the formation of which reserve cells 
play an important role.4,6,13,44
Their specific immunostaining patterns distinguish be-
tween the SOX2-positive ectocervical squamous epithe-
lium on the one hand, and the SOX17-positive endocervical 
glandular (columnar) epithelium on the other (Figure 6A). 
Reserve cells could express SOX17 but not SOX2. In the 
development of metaplasia, reserve cells show a changing 
SOX-expression pattern from SOX17 positivity alone, via 
a complex combination of SOX17 and SOX2 in immature 
metaplasia (IMM), to exclusive SOX2 expression in areas of 
mature squamous metaplastic epithelium (indistinguishable 
from normal squamous epithelium) (Figure 6B). We found 
that in squamous epithelium with an apparently normal his-
tological appearance, areas can be recognized that exhibit the 
SOX expression pattern of IMM (SOX17 positive and SOX2 
negative), an observation that is supported by the typical ker-
atin 17 positivity and absence p16 in these IMM regions.6 The 
comparable SOX17 expression patterns in reserve cells and in 
the remnants of IMM support the general opinion that reserve 
cells are the progenitors for IMM and may therefore provide 
additional evidence for the reserve cell as the progenitor of 
cervical (pre)neoplasia.13,22,43,45 The reserve cells, in turn, are 
suggested to originate from either the basal cells of the squa-
mous epithelium14,46 or from the stretch of cuboidal cells at 
the SqCJ recognized by Herfs et al15 Although we did not 
specifically recognize these stretches of cuboidal cells in our 
tissue samples, it is very likely that these latter cells are also 
SOX17 positive.
In the literature, three different pathways have been 
suggested to lead to the development of (pre)neoplastic 
and finally invasive cervical cancer. The first, well de-
scribed and accepted pathway suggests that HSIL devel-
ops via LSIL and that LSIL originates in the ectocervical 
epithelium by high risk human papilloma virus (hrHPV) 
infection of the basal cell compartment in the squamous 
epithelium.24,41,47,48 A second theory states that HSIL is 
the result of a hrHPV infection of IMM, as concluded 
from the dual expression of keratin 17 and p16 in atypi-
cal squamous lesions with metaplastic features.6,13,22,43,45 
The third pathway involves hrHPV infection of the spe-
cific stretch of endocervical, keratin 7-positive cuboidal 
cells at the SqCJ, producing immediately a HSIL without 
a low-grade precursor lesion.4,5 Our results support the 
view that IMM, originating from reserve cells is the target 
for hrHPV and as a result the origin of HSIL, concluded 
from the fact that we found a switch from SOX17-positive 
and SOX2-negative areas of squamous epithelium (IMM) 
to SOX17-negative and SOX2-positive HSIL which were 
in direct connection with each other (Figures 5 and 6C). 
These observations support previous reports that showed 
HPV positivity by PCR or p16 immunoreactivity in atypi-
cal immature metaplasia.22,23
It was shown previously that SOX2 expression increased 
with severity of SIL lesions, but data in the literature are con-
tradictory.27-33,43 In our study, we detected an equally strong 
nuclear expression of SOX2 in the normal squamous epithe-
lium, as compared to the majority of LSIL, HSIL, and SCC. 
Although it is difficult to draw conclusions about the dif-
ferences in SOX2 expression levels based on immunohisto-
chemical procedures, different experimental conditions used 
(eg, antibody dilution and secondary detection system) could 
explain these discrepancies.
5 |  CONCLUSION
It is generally accepted that the TZ of the uterine cervix 
is the target area for hrHPV infection. Several studies 
hypothesized that in the formation of HSIL HPV first 
F I G U R E  6  Schematic overview of switches in SOX expression 
during formation of metaplasia and SIL in the cervical transformation 
zone. IMM, immature metaplasia; LG, position of the last gland 
(sometimes seen as Nabothian cyst) beneath the squamous epithelium 
formed during the metaplastic process; NSqCJ, new squamocolumnar 
junction at the interface between metaplasia and columnar epithelium; 
OSqCJ, original squamocolumnar junction at the interface between 
squamous epithelium and columnar epithelium; RC, reserve cells
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infects a small population of non-stratified cuboidal 
cells, directly proximal to the SqQJ.15,41,49 In this model, 
the infected cuboidal cell initially dedifferentiates into 
reserve cells, which subsequently give rise to the pre-
neoplastic lesion.41 Our results on SOX2 and SOX17 
expression in the normal and preneoplastic cervix sug-
gest that also existing reserve cells and/or metaplastic 
cells can be the progenitors for HSIL. In this view, the 
multifocal patches of remnant columnar epithelium be-
tween areas of squamous metaplasia in the endocervix 
should be taken into account.6 In our study, we showed 
that these NSqCJ, with metaplastic areas and reserve 
cells beneath the glandular epithelium, are new potential 
targets for HPV infection.
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